L3VLUP
ProSign in

WRBY · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

WRBYLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • WRBY
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterWRBYLLY
Q3 2020none listed holders, n.a.33 holders, $14.1bn
Q4 2020none listed holders, n.a.29 holders, $17.3bn
Q1 2021none listed holders, n.a.24 holders, $23.0bn
Q2 2021none listed holders, n.a.24 holders, $27.8bn
Q3 20216 holders, $2.9bn31 holders, $29.9bn
Q4 20219 holders, $2.7bn31 holders, $34.7bn
Q1 20228 holders, $2.2bn24 holders, $35.3bn
Q2 20228 holders, $683m33 holders, $42.7bn
Q3 20225 holders, $490m31 holders, $43.4bn
Q4 20226 holders, $451m31 holders, $46.6bn
Q1 20235 holders, $341m33 holders, $44.3bn
Q2 20235 holders, $369m37 holders, $59.6bn
Q3 20237 holders, $436m44 holders, $67.6bn
Q4 20237 holders, $413m45 holders, $73.6bn
Q1 20247 holders, $362m41 holders, $95.3bn
Q2 20248 holders, $333m43 holders, $110bn
Q3 20248 holders, $364m45 holders, $107bn
Q4 20249 holders, $517m46 holders, $93.9bn
Q1 202510 holders, $334m42 holders, $98.4bn
Q2 20258 holders, $340m43 holders, $93.2bn
Q3 20259 holders, $408m39 holders, $86.7bn
Q4 20256 holders, $231m41 holders, $123bn
Q1 20268 holders, $203m39 holders, $106bn
Q2 20267 holders, $381m44 holders, $132bn
WRBY

Warby Parker Inc

Holders
8
Reported value
$340m
Buyers
2
Sellers
7

Breadth -5 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
LLY

Eli Lilly & Co

Holders
43
Reported value
$93.2bn
Buyers
25
Sellers
22

Breadth +3 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 47 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only WRBY (4)

Baillie Gifford & Co, Durable Capital Partners LP, First Eagle Investment Management LLC, PDT Partners LLC

Only LLY (39)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, and 14 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →